Patient Preferences in the Treatment of NSCLC

Lara Kujtan, assistant professor at the UMKC School of Medicine, discusses its importance
Read the OncLive interview about the importance of patient preferences in the treatment of oncogene-driven non-small cell lung cancer (NSCLC).
Published: Jan 22, 2019